In this context, the PD-L1–mediated inhibition of PTP1B in these TNBC cells is more likely tumor promoting, which may recapitulate the tumor-suppressing role of PTP1B in the immune system that normally expresses high levels of PD-L1. The gene discussed is PTPN1; the disease is neoplasm.